About
Qvella Corporation is a molecular diagnostics and biotechnology company based in Richmond Hill, Ontario, with operations in Carlsbad, California. Founded in 2009, the company focuses on improving the detection and management of bloodstream infections, particularly sepsis, by significantly reducing the time needed to identify infectious pathogens from blood samples. The company's key innovation is its Field Activated Sample Treatment (FAST) technology, which allows for the rapid isolation, lysis, amplification, and detection of ribosomal RNA from pathogens in blood. This technology can detect over 90% of pathogens causing bloodstream infections within minutes, a major advancement compared to traditional methods that can take hours or days. Qvella is developing the FAST ID™ BSI Panel, which aims to deliver timely microbiology results to enhance patient outcomes and reduce mortality linked to delayed antimicrobial therapy. Qvella serves hospitals, clinical laboratories, and healthcare providers, focusing on fast and accurate pathogen identification to support effective treatment decisions. The company is dedicated to advancing its diagnostic technologies for future commercialization.
Technologies
Keywords
Company Information
-
Employees 26
-
Founded 2009
-
Annual Revenue $10000000
-
Total Funding $39720287
Location
Richmond Hill, Ontario, Canada
